Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease

BackgroundNon-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac manifestation of metabolic syndrome. NAFLD is strongly linked to CAD and hepatic steatosis is an independent risk factor for CAD and cardiac mortali...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ open gastroenterology 2016-01, Vol.3 (1), p.e000096-e000096
Hauptverfasser:	Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Cardiovascular disease Cell adhesion & migration Cell growth Chronic illnesses Coronary vessels Gene expression Hepatitis Hepatology Homeostasis Liver diseases Mammals Medical imaging Metabolic syndrome MicroRNAs Mortality Plasma Proteins Smooth muscle Studies Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!